DD283620A5 - Verfahren zur herstellung neuer 2,3,4-substituierte imidazole und 3,4,5-substituierte 1,2,4-triazole - Google Patents

Verfahren zur herstellung neuer 2,3,4-substituierte imidazole und 3,4,5-substituierte 1,2,4-triazole Download PDF

Info

Publication number
DD283620A5
DD283620A5 DD89326949A DD32694989A DD283620A5 DD 283620 A5 DD283620 A5 DD 283620A5 DD 89326949 A DD89326949 A DD 89326949A DD 32694989 A DD32694989 A DD 32694989A DD 283620 A5 DD283620 A5 DD 283620A5
Authority
DD
German Democratic Republic
Prior art keywords
halogen
aryl
ring
alkyl
formula
Prior art date
Application number
DD89326949A
Other languages
German (de)
English (en)
Inventor
Kurt Schromm
Anton Mentrup
Ernst-Otto Renth
Hubert Heuer
Gojko Muacevic
Franz Birke
Original Assignee
�������@������������@��k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@������������@��k�� filed Critical �������@������������@��k��
Publication of DD283620A5 publication Critical patent/DD283620A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD89326949A 1988-03-30 1989-03-28 Verfahren zur herstellung neuer 2,3,4-substituierte imidazole und 3,4,5-substituierte 1,2,4-triazole DD283620A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3810848A DE3810848A1 (de) 1988-03-30 1988-03-30 Neue 2,3,4-substituierte imidazole und 3,4,5-substituierte 1,2,4-triazole, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
DD283620A5 true DD283620A5 (de) 1990-10-17

Family

ID=6351100

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89326949A DD283620A5 (de) 1988-03-30 1989-03-28 Verfahren zur herstellung neuer 2,3,4-substituierte imidazole und 3,4,5-substituierte 1,2,4-triazole

Country Status (18)

Country Link
EP (1) EP0335381A1 (fr)
JP (1) JPH02503679A (fr)
KR (1) KR900700459A (fr)
AU (1) AU3228689A (fr)
DD (1) DD283620A5 (fr)
DE (2) DE3810848A1 (fr)
DK (1) DK151489A (fr)
FI (1) FI891449A (fr)
FR (1) FR2629457A1 (fr)
GB (1) GB2216890A (fr)
HU (1) HUT52091A (fr)
IL (1) IL89788A0 (fr)
NO (1) NO891293L (fr)
PL (1) PL278547A1 (fr)
PT (1) PT90142A (fr)
WO (1) WO1989009212A1 (fr)
YU (1) YU65489A (fr)
ZA (1) ZA892259B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3927483A1 (de) * 1989-08-19 1991-02-21 Boehringer Ingelheim Kg Neue substituierte heterocyclische fuenfringe, ihre herstellung und verwendung
US5120749A (en) * 1991-02-20 1992-06-09 Abbott Laboratories Platelet activating antagonists
US5155117A (en) * 1991-04-12 1992-10-13 G. D. Searle & Co. 1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders
DE69232003T2 (de) * 1991-09-18 2002-04-25 Glaxo Group Ltd., Greenford Benzanilidderivate als 5-HT1D-Antagonisten
WO2004005262A2 (fr) 2002-07-02 2004-01-15 Schering Corporation Nouveaux antagonistes des recepteurs du neuropeptide y y5
MXPA04011363A (es) * 2002-07-04 2005-02-14 Aventis Pharma Sa Nuevos derivados acil hidrazino del tiofeno, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion.
US20040192728A1 (en) 2003-02-03 2004-09-30 Ellen Codd Quinoline-derived amide modulators of vanilloid VR1 receptor
WO2006076592A1 (fr) 2005-01-14 2006-07-20 Cgi Pharmaceuticals, Inc. Urees a substitution 1,3-diaryle, modulateurs de l'activite de kinases
US7777040B2 (en) 2005-05-03 2010-08-17 Cgi Pharmaceuticals, Inc. Certain substituted ureas, as modulators of kinase activity
UY30892A1 (es) 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
EP4242206A1 (fr) 2009-01-30 2023-09-13 Novartis AG Forme crystalline du chlorhydrate de n-{(1-5)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophene carboxamide
ES2575215T3 (es) 2009-12-11 2016-06-27 Autifony Therapeutics Limited Derivados de imidazolidindiona
JP5913357B2 (ja) 2010-12-06 2016-04-27 アウトイフオンイ トヘラペウトイクス リミテッド Ｋｖ３阻害剤として有用なヒダントイン誘導体
EP2718285B1 (fr) 2011-06-07 2016-03-16 Autifony Therapeutics Limited Dérivés d'hydantoïne utiles en tant qu'inhibiteurs de kv3
JP2015517563A (ja) 2012-05-22 2015-06-22 アウトイフオンイ トヘラペウトイクス リミテッド Ｋｖ３阻害剤としてのヒダントイン誘導体
JP6240667B2 (ja) 2012-05-22 2017-11-29 アウトイフオンイ トヘラペウトイクス リミテッド Ｋｖ３阻害剤としてのトリアゾール
US11091447B2 (en) 2020-01-03 2021-08-17 Berg Llc UBE2K modulators and methods for their use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3842089A (en) * 1971-08-18 1974-10-15 Upjohn Co 4-(alpha-(phenyl)-o-toly)-4h-1,2,4-triazoles
GB1378617A (en) * 1972-05-05 1974-12-27 Upjohn Co Triazolylbenzophenones
FR2269938A2 (en) * 1974-05-08 1975-12-05 Delalande Sa 5-Hydroxymethyl-3,4-diphenyl-1,2,4-triazoles - with anticholinergic, bronchodilator, antidepressant, analgesic, vasodilator activity, etc.
FR2539127B1 (fr) * 1983-01-10 1985-08-23 Roussel Uclaf Nouveaux derives du 4h-1,2,4-triazole, leur procede de preparation et leur application comme medicaments
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
YU136287A (en) * 1986-07-25 1990-06-30 Boehringer Kg Process for preparing new 1,4 benzodiazepines
FR2813807B1 (fr) * 2000-09-14 2002-11-15 Filtrauto Filtre a gazole incluant un circuit electrique et dispositif de filtration comportant un tel filtre

Also Published As

Publication number Publication date
DE3810848A1 (de) 1989-10-19
GB2216890A (en) 1989-10-18
DK151489A (da) 1989-10-01
PL278547A1 (en) 1990-01-08
FI891449A (fi) 1989-10-01
DE3990284D2 (en) 1990-04-05
NO891293D0 (no) 1989-03-28
IL89788A0 (en) 1989-09-28
PT90142A (pt) 1989-11-10
KR900700459A (ko) 1990-08-13
FR2629457A1 (fr) 1989-10-06
HUT52091A (en) 1990-06-28
YU65489A (en) 1991-04-30
AU3228689A (en) 1989-10-05
WO1989009212A1 (fr) 1989-10-05
NO891293L (no) 1989-10-02
ZA892259B (en) 1990-12-28
FI891449A0 (fi) 1989-03-28
DK151489D0 (da) 1989-03-29
EP0335381A1 (fr) 1989-10-04
JPH02503679A (ja) 1990-11-01
GB8907042D0 (en) 1989-05-10

Similar Documents

Publication Publication Date Title
DE69830403T2 (de) Inhibitoren des faktors xa mit einer neutralen gruppe mit p1-spezifität
DD283620A5 (de) Verfahren zur herstellung neuer 2,3,4-substituierte imidazole und 3,4,5-substituierte 1,2,4-triazole
JP3466265B2 (ja) ベンゾイミダゾール化合物及び中枢神経系疾患治療薬
DE60001190T2 (de) Aminotriazolverbindungen, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
EP0497852B1 (fr) Bicyclo-imidazoles, procede pour leur fabrication et medicaments les contenant
EP1917251B1 (fr) Composes 5-cycle-heteroaromates et leur utilisation en tant que partenaires de liaison des recepteurs 5-ht5
CH649546A5 (de) Indol-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
DE69708269T2 (de) Chinoxalindione
EP0612741A1 (fr) Dérivés cycliques, médicaments les contenant et procédé pour leur préparation
EP0608858A1 (fr) Dérivés hétérocycliques à 5 chaînons comme inhibiteurs d'aguégation
DE2625227A1 (de) Heteroarylverbindung, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
EP0777667A1 (fr) Derives cycliques d'uree-benzazepine a effet inhibiteur de l'agregation
DE4036645A1 (de) Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung
DE60010126T2 (de) Verzweigte substituierte aminoderivate vom 3-amino-1-phenyl-1h(1,2,4)triazol, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE3445691A1 (de) Amidinderivate, verfahren zu ihrer herstellung und pharmazeutische mittel
DE60318584T2 (de) Arylimidazolderivate und deren verwendung als no-synthase-inhibitoren und als modulatoren der na-kanäle
WO1991002730A1 (fr) Nouveaux composes a noyau pentagonal heterocycliques substitues, leur fabrication et leur application
DE69404322T2 (de) 3-aryl-4-alkyl und 4,5-dialkyl-4h-1,2,4-triazole, verwendbar gegen gedächtnis-störungen
JPH03209369A (ja) トリアゾロ誘導体、その製造方法、およびその誘導体を活性成分とする抗狭心症剤または精神安定・鎮静剤組成物とその製造方法
WO1991002731A1 (fr) N-heterocycles substitues, leur fabrication et leur application
EP0037471B1 (fr) 1-Aroyl-2-phénylamino-2-imidazolines, leur préparation et leurs compositions pharmaceutiques
EP0434982B1 (fr) Dérivés de 5-(amino)-triazolylcarbothioamide, procédé pour leur préparation et médicaments les contenant, ainsi que l'utilisation de ces premiers
DE69609172T2 (de) 3-phenyl-1,4-dialkyl-1,2,4-triazolium salze und ihre verwendung als antidepressiva
WO2001004099A1 (fr) Benzolpyridazines
DE2554701A1 (de) 3,4-disubstituierte 2-(beta-naphthyloxy)-aethylpyrazolone

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee